Development of classification and regression based QSAR models to predict rodent carcinogenic potency using oral slope factor

Ecotoxicology and Environmental Safety

Volumn 82, Issue , 2012, Pages 85-95

  Kar, Supratik ^a   Deeb, Omar ^b   Roy, Kunal ^a  

^a JADAVPUR UNIVERSITY   (India)

^b AL QUDS UNIVERSITY   (Palestine)

Author keywords

Carcinogenicity; LDA; OECD; OSF; PDD; QSAR

Indexed keywords

CARCINOGEN;

CARCINOGEN; MODEL VALIDATION; POLLUTION EXPOSURE; REGRESSION ANALYSIS; RODENT; TOXICOLOGY;

ARTICLE; CARCINOGEN TESTING; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHEMICAL STRUCTURE; CLASSIFICATION; DISCRIMINANT ANALYSIS; LINEAR DISCRIMINANT ANALYSIS; MATHEMATICAL ANALYSIS; ORAL SLOPE FACTOR; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; RISK ASSESSMENT;

ANIMALS; CARCINOGENS; DATABASES, CHEMICAL; DISCRIMINANT ANALYSIS; HUMANS; MICE; MODELS, THEORETICAL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; SOFTWARE;

RODENTIA;

EID: 84863000719     PISSN: 01476513     EISSN: 10902414     Source Type: Journal    
DOI: 10.1016/j.ecoenv.2012.05.013     Document Type: Article

References (60)

1. Ashby J., Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemical tested by the US NTP. Mutat. Res. 1991, 257:229-306.
2. Benigni R., Giuliani A. Putting the Predictive Toxicology Challenge into Perspective: Reflections on the Results. Bioinformatics 2003, 19:1194-1200.
3. Benigni R., Zito R. The second National Toxicology Program comparative exercise on the prediction of rodent carcinogenicity: definitive results. Mutat. Res. 2004, 566:49-63.
4. CDER, 1997. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. S1B. Testing for carcinogenicity of pharmaceuticals.
5. Cerius2, Version 4.10 Software is a Product of Accelrys Inc., San Diego, CA, USA. http://www.accelrys.com/cerius2.
6. Consonni V., Ballabio D., Todeschini R. Evaluation of model predictive ability by external validation techniques J. Chemometrics 2010, 24:194-201.
7. Darlington R.B. Regression and Linear models 1990, McGrawHill, New York.
8. Deeb O. Correlation ranking and stepwise regression procedures in principal components artificial neural networks modeling with application to predict toxic activity and human serum albumin binding affinity. Chemom. Intell. Lab. Syst. 2010, 104:181-194.
9. DRAGON ver. 6 is software of TALETE srl, Italy, . http://www.talete.mi.it/products/dragon_molecular_descriptors.htm.
10. Enoch B.S.J., Cronin M.T.D. A review of the electrophilic reaction chemistry involved in covalent DNA binding. Crit. Rev. Toxicol. 2010, 40(8):728-748.
11. European Commission, 2006. Directive 2006/121/EC of the European Parliament and of the Council of 18 December 2006 amending Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances in order to adapt it to Regulation (EC) No. 1907/2006 concerning the REACH and establishing a European Chemicals Agency. Official Publications of the European Communities (OPOCE), Luxembourg.
12. Fan Y., Shi L.M., Kohn K.W., Pommier Y., Weinstein J.N. Quantitative Structure-Antitumor Activity Relationships of Camptothecin Analogues: Cluster Analysis and Genetic Algorithm-Based Studies. J. Med. Chem. 2001, 44:3254-3263.
13. Fawcett T. An introduction to ROC analysis. Pattern Recogn. Lett. 2006, 27:861-874.
14. Gálvez-Llompart M., Recio M.C., García-Domenech R. Topological virtual screening: a way to find new compounds active in ulcerative colitis by inhibiting NF-κB. Mol. Divers 2011, 15:917-926.
15. Geisser S. The Predictive Sample Reuse Method with Application. J. Amer. Stat. Ass. 1975, 70:320-328.
16. Golbraikh A., Tropsha A. Beware of q2!. J. Mol. Graph. Model 2002, 20:269-276.
17. Gramatica P. Principles of QSAR Models Validation: Internal and External. QSAR Comb. Sci. 2007, 26:694-701.
18. Hemmateenejad B., Miri R., Safarpour M.A., Khoshneviszadeh M., Edraki N. Conformational analysis of some new derivatives of 4-nitroimidazolyl-1,4-dihydropyridine based calcium channel blockers. J. Mol. Struct. (Theochem.) 2005, 717:139-152.
19. Hyperchem Release 8.0.3 for windows, Hypercube Inc. copyright 2007.
20. IARC Monographs on the evaluation of carcinogenic risks to humans, Lyon, France, 2006. Available from: . http://monographs.iarc.fr.
21. IRIS Progress Report, August 2011. http://www.epa.gov/iris.
22. Jelcic Z. Solvent molecular descriptors on poly (D, L-lactide-co-glycolide) particle size in emulsification-diffusion process. Colloids and Surfaces A: Physicochem. Eng. Aspects 2004, 242:159-166.
23. Kar S., Harding A.P., Roy K., Popelier P.L.A. QSAR with Quantum Topological Molecular Similarity Indices: Toxicity of Aromatic Aldehydes to Tetrahymena pyriformis. SAR QSAR. Environ. Res. 2010, 21:149-168.
24. Kar S., Roy K. Predictive toxicology using QSAR: A perspective. J. Indian Chem. Soc. 2010, 87:1455-1515.
25. Kar S., Roy K. Development and validation of a robust QSAR model for prediction of carcinogenicity of drugs. Indian J. Biochem. Biophys. 2011, 48:111-122.
26. Kar, S., Roy, K., 2012. First report on development of quantitative interspecies structure-carcinogenicity relationship models and exploring discriminatory features for rodent carcinogenicity of diverse organic chemicals using OECD guidelines. Chemosphere 87, 339-355.
27. Kier L.B., Hall L.H., Frazer J.W. An index of electrotopological state for atoms in molecules. J. Math. Chem. 1991, 7:229-241.
28. Klaassen C.D., Watkins J.B. Casarett & Doull's Toxicology, Companion Handbook: The Basic Science of Poisons 1999, McGraw-Hill, New York. 5th ed.
29. Massarelli I., Imbriani M., Coi A., Saraceno M., Carli N., Bianucci A.M. Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals. Eur. J. Med. Chem. 2009, 44:3658-3664.
30. Matthews B.W. Comparison of the Predicted and Observed Secondary Structure of T4 Phage Lysozime. Biochim. Biophys. Acta 1975, 405:442-451.
31. MINITAB is a Statistical Software of Minitab Inc., USA, . http://www.minitab.com.
32. Mitra I., Saha A., Roy K. Exploring quantitative structure-activity relationship (QSAR) studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants. Mol. Simul. 2010, 36:1067-1079.
33. Mitteroecker P., Bookstein F. Linear Discrimination, Ordination, and the isualization of Selection Gradients in Modern Morphometrics. Evol. Biol. 2011, 38:100-114.
34. Müller L., Kikuchi Y., Probst G., Schechtman L., Shimada H., Sofuni T. ICH harmonized guidance on genotoxicity testing of pharmaceuticals; evolution, reasoning and impact. Mutat. Res. 1999, 436:195-225.
35. Murcia-Soler M., Pérez-Giménez F., Garc'ia-March F.J., Salabert-Salvador M.T., D'iaz-Villanuev W., Medina-Casamayor P. Discrimination and selection of new potential antibacterial compounds using simple topological descriptors. J. Mol. Graph. Model. 2003, 21:375-390.
36. National Toxicology Program U.S. Department of Health and Human Services 2005, Public Health Service.
37. OECD Document, 2007. Guidance Document on the Validation of (Quantitative) 1226.
38. Structure-Activity Relationships (Q)SARs] Models, ENV/JM/MONO(2007)2.
39. 2 metrics for validation of QSPR models. Chemom. Intell. Lab. Syst. 2011, 107:194-205.
40. Perez-Garrido A., Helguera A.M., Borges F., Cordeiro M.N.D.S., Rivero V., Escudero A.G. Two New Parameters Based on Distances in a Receiver Operating Characteristic Chart for the Selection of Classification Models. J. Chem. Inf. Model. 2011, 51:2746-2759.
41. Prado-Prado F.J., Uriarte E., Borges F., Gonza'lez-Di'az H. Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs. Eur. J. Med. Chem. 2009, 44:4516-4521.
42. Putz M.V., Ionaşcu C., Putz A.M., Ostafe V. Alert-QSAR. Implications for Electrophilic Theory of Chemical Carcinogenesis. Int. J. Mol. Sci. 2011, 12:5098-5134.
43. Rogers D., Hopfinger A.J. Application of Genetic Function Approximation to Quantitative Structure Activity Relationships and Quantitative Structure Property Relationships. J. Chem. Inf. Comput. Sci. 1994, 34:854-866.
44. Roy K., Mitra I. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design. Comb. Chem. High Throughput Screen 2011, 14:450-474.
45. Roy, K., Mitra, I., Kar, S., Ojha, P., Das, R.N., Kabir, H., 2012. Comparative studies on some metrics for external validation of QSPR models. J. Chem. Inf. Model. 52, 396-408.
46. Schüürmann G., Ebert R.-U., Chen J., Wang B., Kühne R. External validation and prediction employing the predictive squared correlation coefficient-test set activity mean vs. training set activity mean. J. Chem. Inf. Model. 2008, 48(11):2140-2145.
47. Shahlaei M., Sabet R., Ziari M.B., Moeinifard B., Fassihi A., Karbakhsh R. QSAR study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using LS-SVM and GRNN based on principal components. Eur. J. Med. Chem. 2010, 45:4499-4508.
48. SIMCA-P 10.0, UMETRICS, Umea, Sweden, 2002. http://www.umetrics.com.
49. SPSS is a statistical software of SPSS Inc., USA. http://www.spss.com.
50. STATISTICA is a Statistical Software of STATSOFT Inc., USA, . http://www.statsoft.com/.
51. Tanno M., Sueyoshi S., Miyata N., Nakagawa S. Nitric Oxide Generation from Aromatic N-Nitrosoureas at Ambient Temperature. Chem. Pharm. Bull. 1996, 44:1849-1852.
52. Toropova A.P., Toropov A.A., Lombardo A., Roncaglioni A., Benfenati E., Gini G. A new bioconcentration factor model based on SMILES and indices of presence of atoms. Eur. J. Med. Chem. 2010, 5:4399-4402.
53. US EPA Integrated Risk Information System 2009, US Environmental Protection Agency, National Center for Environmental Assessment, Washington, DC, Available from: 〈http://www.epa.gov/iris/〉 [accessed 1 January 2011].
54. USEPA IRIS database. http://www.epa.gov/iris/.
55. Wang N.C.Y., Venkatapathy R., Bruce R.M., Moudgal C. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency. Regul. Toxicol. Pharm. 2011, 59:215-226.
56. Ward J.M. Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans. Asian Pac. J. Cancer Preven. 2010, 11:18.
57. Williams E.S., Panko J., Paustenbach D.J. The European Union's REACH regulation: a review of its history and requirements. Crit. Rev. Toxicol. 2009, 39:553-675.
58. Wold S. Chemometric Methods in Molecular Design 1995, 195-218. VCH, Weinheim. H. van de Waterbeemd (Ed.).
59. Wold S., Sjostrom M., Eriksson L. Partial least squares projections to latent structures (PLS) in chemistry. Encyclopedia of Comparative Chemistry 1998, Vol. 3. Wiley, Chichester, GB.
60. Wold S., Sjostrom M., Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom. Intell. Lab. Syst. 2001, 58:109-130.